I have been following there recommendations on DIA, SPY and QQQQ and find them accurate and timely. Well done for a solid service. I want to tell you that I can't compare anyone to them in terms of the daily analysis. For someone like me, who is familiar with technical analysis and has used it for two decades, it is very rare to hear from anyone who will share their analysis like they do. Watch the daily video its free, and maybe it can help you like it has helped me.
Visit StockMarketVideop (Google them)
My guess would be Antares Pharm (ATRS). Teva is currently working on four products in which Antares will provide injectors. It will be cheaper for Teva to own Antares than it will be to pay for all those injectors if the four products launch. EPI pen is one of the products and that will likely turn out to be huge. Has anyone heard when Teva will launch EPI. I know they have to wait until sometime after June 22, 2015
Sentiment: Strong Buy
Dr. frost recently invested on small cap biotech companies like atnm and svon i also noticed he was named the Chairman of the Board of Teva Pharmaceutical Industries, Ltd, or Teva (NYSE:TEVA) in March 2010 and had previously been Vice Chairman since January 2006 when Teva acquired IVAX Corporation.
which kind of biotech companies teva is looking for?
Webinar on Unique Device Identification (UDI): What & How within overall Medical Device Value Chain.
Planning and Implementation of the Medical Device Regulation (UDI)
Step 1. Developing the UDI compliance plan
Brief senior management on project scope and provide resource requirements with cost
Receive senior management project approval
Build the right team members who are dedicated and have the right complement of product/process knowledge
Define clear roles, accountabilities and responsibilities
Understand the requirements of the Medical Device Regulation
Engage in an approach that will confirm assumptions early and allow for joint agreed adjustment to the plan
Evaluate the supply chain business processes
Produce gap assessment and generate gap findings and conclusions
Prepare for innovative and sustainable change to the go-forward environment - monitor publications
Plan and provide that product experts enable knowledge transfer
Develop a plan for Change Management
Step 2. Understanding the Machine Readable Technology
That number on the medical device, It's not just a number....It means something
Standard product identifier
Reach out to the global community
Benefit to the medical community
Step 3. Change Management
Create compelling story or business case
Build a team who are fully committed to the change initiative
Create the vision
Communication, Communication, Communication
Start with "short term" wins
Step 4. Risk Assessment keeping the system agile for future changes
Proactively identify and manage risks
Assess Labeling changes - Global Packaging
Supply Chain continuity planning
Step 5. Implementation of UDI plan across the value chain
Review with project team key points of requirement
Identify the representative products for assessments
Build implementation road map, resourcing including cost
I agree, I'm placing my buy order in tonight good till filled, for $39. but then again. why??? When I can get 3 shares of OPK for less than that...
I guess they must get paid to post spam that dilutes the conversation, makes them an obstacle to dialogue, and shows their ignorance of any company's reality. I believe the term is obfuscation. Not a real productive use of anyones time. But somebody must be dumb enough to buy this #$%$.Yahoo must get a kickback or it would have stopped long ago. GLTA (except the spamming losers)
Is anyone hearing/reading any speculation about TEVA buying Concert Pharma. ? There are some tidbits out there but I'm wondering if it is just wishful thinking by CNCE investors.